Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank57
3Y CAGR-3.6%
5Y CAGR+19.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-3.6%/yr
vs +58.9%/yr prior
5Y CAGR
+19.6%/yr
Recent deceleration
Acceleration
-62.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$27.55M-2.9%
2024$28.36M-12.4%
2023$32.37M+5.3%
2022$30.75M+41.5%
2021$21.73M+93.2%
2020$11.25M+128.2%
2019$4.93M+2.2%
2018$4.82M-